BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36279818)

  • 1. Benign prostatic hyperplasia in the dog.
    Cunto M; Ballotta G; Zambelli D
    Anim Reprod Sci; 2022 Dec; 247():107096. PubMed ID: 36279818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical approach to prostatic diseases in the dog.
    Cunto M; Mariani E; Anicito Guido E; Ballotta G; Zambelli D
    Reprod Domest Anim; 2019 Jun; 54(6):815-822. PubMed ID: 30974484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine Prostate Disease.
    Christensen BW
    Vet Clin North Am Small Anim Pract; 2018 Jul; 48(4):701-719. PubMed ID: 29933768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
    Niżański W; Levy X; Ochota M; Pasikowska J
    Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theriogenology question of the month. Benign prostatic hypertrophy (BPH), prostatitis, and prostatic neoplasia.
    Root Kustritz M; Merkel L
    J Am Vet Med Assoc; 1998 Sep; 213(6):807-9. PubMed ID: 9743718
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the GnRH stimulation test on Canine Prostatic-Specific Esterase (CPSE).
    Ferré-Dolcet L; Pisu MC; Attard S; Romagnoli S
    Reprod Domest Anim; 2023 Aug; 58(8):1125-1131. PubMed ID: 37337834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic fluid composition and semen quality in dogs with benign prostatic hyperplasia undergoing treatment with osaterone acetate.
    Ferré-Dolcet L; Frigotto L; Contiero B; Bedin S; Romagnoli S
    Reprod Domest Anim; 2022 Jan; 57(1):72-79. PubMed ID: 34706118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
    Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
    Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimentally induced benign prostatic hyperplasia with Tadalafil and castration in dogs.
    Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
    Theriogenology; 2020 Jan; 142():236-245. PubMed ID: 31711694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm quality and selected biochemical parameters of seminal fluid in dogs with benign prostatic hyperplasia.
    Krakowski L; Wąchocka A; Brodzki P; Wrona Z; Piech T; Wawron W; Chałabis-Mazurek A
    Anim Reprod Sci; 2015 Sep; 160():120-5. PubMed ID: 26275963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
    Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
    J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
    Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
    J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
    Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
    Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethral bleeding as a presenting sign of benign prostatic hyperplasia in the dog: a retrospective study (1979-1993).
    Read RA; Bryden S
    J Am Anim Hosp Assoc; 1995; 31(3):261-7. PubMed ID: 7543358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
    Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
    Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diseases of the prostate in the dog].
    Arbeiter K
    Tierarztl Prax; 1987; 15(3):291-4. PubMed ID: 2447680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of the GnRH agonist (deslorelin) in dogs affected by benign prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound.
    Polisca A; Orlandi R; Troisi A; Brecchia G; Zerani M; Boiti C; Zelli R
    Reprod Domest Anim; 2013 Aug; 48(4):673-80. PubMed ID: 23320475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
    Socha P; Zduńczyk S; Tobolski D; Janowski T
    Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.
    Angrimani DSR; Brito MM; Rui BR; Nichi M; Vannucchi CI
    Sci Rep; 2020 Sep; 10(1):14834. PubMed ID: 32908208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of benign prostatic hyperplasia on sperm morphological features and sperm DNA integrity in dogs.
    Flores RB; Angrimani D; Rui BR; Brito MM; Abreu RA; Vannucchi CI
    Reprod Domest Anim; 2017 Apr; 52 Suppl 2():310-315. PubMed ID: 27774660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.